NM_000070.3:c.1992+110T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000070.3(CAPN3):​c.1992+110T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.711 in 1,109,212 control chromosomes in the GnomAD database, including 284,280 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.76 ( 45566 hom., cov: 32)
Exomes 𝑓: 0.70 ( 238714 hom. )

Consequence

CAPN3
NM_000070.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.44

Publications

7 publications found
Variant links:
Genes affected
CAPN3 (HGNC:1480): (calpain 3) Calpain, a heterodimer consisting of a large and a small subunit, is a major intracellular protease, although its function has not been well established. This gene encodes a muscle-specific member of the calpain large subunit family that specifically binds to titin. Mutations in this gene are associated with limb-girdle muscular dystrophies type 2A. Alternate promoters and alternative splicing result in multiple transcript variants encoding different isoforms and some variants are ubiquitously expressed. [provided by RefSeq, Jul 2008]
CAPN3 Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive limb-girdle muscular dystrophy type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae)
  • muscular dystrophy, limb-girdle, autosomal dominant 4
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • muscular dystrophy, limb-girdle, autosomal dominant
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 15-42409490-T-C is Benign according to our data. Variant chr15-42409490-T-C is described in ClinVar as Benign. ClinVar VariationId is 678278.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.925 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000070.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CAPN3
NM_000070.3
MANE Select
c.1992+110T>C
intron
N/ANP_000061.1
CAPN3
NM_024344.2
c.1974+110T>C
intron
N/ANP_077320.1
CAPN3
NM_173087.2
c.1716+110T>C
intron
N/ANP_775110.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CAPN3
ENST00000397163.8
TSL:1 MANE Select
c.1992+110T>C
intron
N/AENSP00000380349.3
CAPN3
ENST00000357568.8
TSL:1
c.1974+110T>C
intron
N/AENSP00000350181.3
CAPN3
ENST00000349748.8
TSL:1
c.1716+110T>C
intron
N/AENSP00000183936.4

Frequencies

GnomAD3 genomes
AF:
0.764
AC:
116154
AN:
152050
Hom.:
45516
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.933
Gnomad AMI
AF:
0.779
Gnomad AMR
AF:
0.733
Gnomad ASJ
AF:
0.791
Gnomad EAS
AF:
0.434
Gnomad SAS
AF:
0.707
Gnomad FIN
AF:
0.673
Gnomad MID
AF:
0.759
Gnomad NFE
AF:
0.709
Gnomad OTH
AF:
0.772
GnomAD4 exome
AF:
0.703
AC:
672391
AN:
957044
Hom.:
238714
AF XY:
0.704
AC XY:
345964
AN XY:
491408
show subpopulations
African (AFR)
AF:
0.938
AC:
22052
AN:
23516
American (AMR)
AF:
0.698
AC:
25189
AN:
36080
Ashkenazi Jewish (ASJ)
AF:
0.782
AC:
17571
AN:
22472
East Asian (EAS)
AF:
0.439
AC:
15360
AN:
35002
South Asian (SAS)
AF:
0.728
AC:
51895
AN:
71328
European-Finnish (FIN)
AF:
0.660
AC:
33083
AN:
50098
Middle Eastern (MID)
AF:
0.781
AC:
3747
AN:
4800
European-Non Finnish (NFE)
AF:
0.705
AC:
472170
AN:
670158
Other (OTH)
AF:
0.719
AC:
31324
AN:
43590
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
11358
22716
34073
45431
56789
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9290
18580
27870
37160
46450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.764
AC:
116263
AN:
152168
Hom.:
45566
Cov.:
32
AF XY:
0.759
AC XY:
56431
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.933
AC:
38778
AN:
41556
American (AMR)
AF:
0.732
AC:
11198
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.791
AC:
2744
AN:
3470
East Asian (EAS)
AF:
0.436
AC:
2243
AN:
5150
South Asian (SAS)
AF:
0.708
AC:
3410
AN:
4816
European-Finnish (FIN)
AF:
0.673
AC:
7114
AN:
10578
Middle Eastern (MID)
AF:
0.769
AC:
226
AN:
294
European-Non Finnish (NFE)
AF:
0.709
AC:
48222
AN:
67990
Other (OTH)
AF:
0.767
AC:
1618
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1356
2711
4067
5422
6778
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
848
1696
2544
3392
4240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.729
Hom.:
77593
Bravo
AF:
0.776
Asia WGS
AF:
0.586
AC:
2038
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Muscular dystrophy, limb-girdle, autosomal dominant 4 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal recessive limb-girdle muscular dystrophy type 2A Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.092
DANN
Benign
0.42
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3115883; hg19: chr15-42701688; COSMIC: COSV55518327; COSMIC: COSV55518327; API